U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580716) titled 'Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis' on April 23.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Primary Knee Osteoarthritis
Intervention:
DRUG: Allocetra
Allocetra is a cell-based therapy consisting of non-HLA-matched allogeneic peripheral blood mononuclear cells, induced to an apoptotic stable state.
OTHER: Placebo
Th...